Linseed Capital

Linseed Capital operates as an angel investment firm, strategically deploying capital across diverse business sectors. The firm rigorously identifies companies with viable products, strong market prospects, competitive advantages, and capable management teams. Beyond financial returns, Linseed Capital seeks investments fostering job creation and economic development, particularly in the Midwest, alongside broader societal or environmental impact.

Co-founded and managed by Jim and Karen Linder, the firm leverages their extensive entrepreneurial and corporate leadership. Karen Linder founded and successfully exited Heartland Pathology, Inc., while Jim Linder held significant roles in academia and the corporate sector. Their collaborative endeavor, established around 2012, arose from an insight to provide crucial strategic capital and foster innovation.

Linseed Capital primarily invests in high-potential startups led by impactful individuals building quality products. The firm actively nurtures the entrepreneurial ecosystem, mentoring founders and engaging with leadership teams, especially within the Midwest. Its vision integrates strong financial performance with sustainable growth, positive societal impact, and regional economic vitality.